Insights from Amy Hartigan, Vice President, Claims, Berkley Accident and Health In an era of rising health care costs and increasing scrutiny over fiduciary responsibility, Berkley Accident and Health has introduced a forward-thinking solution to help employers safeguard their self-funded health plans. The Payment Integrity endorsement, now included automatically on all new and renewal Stop Read More
Medical inflation continues to outpace inflation in the rest of the economy.1 This creates headwinds for employers in every industry. What is not as commonly known is that medical inflation affects Stop Loss carriers more severely than self-funded employers, which has a downstream impact on the Stop Loss rates. Let’s examine why this happens and Read More
It’s our pleasure to welcome Mike Madden back to the Berkley Accident and Health team after more than 10 years away. He rejoined the organization in 2024 as Senior Vice President of Captive Growth Strategy. We asked Mike his thoughts on Berkley Accident and Health and why he’s bullish on Group Captive programs. Q: Welcome Read More
Berkley Accident and Health is committed to improving the way employers fund their health care benefits, using a more transparent, flexible, and controlled approach. In November 2024, we launched PBM Checkup, an innovative program that helps Berkley’s Stop Loss policyholders gain insight into their prescription drug costs. We asked Theresa Galizia, Chief Underwriting Officer and Read More
When you buy a health insurance policy, you’re joining a risk pool. Your insurance premiums and claims are mingled with all the insurer’s other customers. Even if your health plan is running well, your premiums may go up if everyone else’s plans are running poorly. That’s because you’re sharing the risk and sharing the results. Read More
With a group captive program, employers can gain clarity and control over their health care costs. In this video, take a deeper dive into the mechanics of risk sharing.
Cell and gene therapy treatments are a groundbreaking frontier in medical treatment, promising not just to alleviate symptoms, but potentially cure life-threatening diseases. These therapies work by altering the genetic material inside a patient’s cells, offering solutions to genetic disorders and diseases previously deemed untreatable. How Cell and Gene Therapy Works At its core, cell Read More
This story demonstrates the success that Berkley Edge can have in helping control high-dollar claims.
Read our March 2024 update on the cell and gene therapy pipeline, with an in-depth look at Casgevy